Thermo Fisher Scientific to Invest $24 Million to Expand Global Bioproduction Capabilities
The company will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media.
Thermo Fisher Scientific announced it will invest $24 million into its Inchinnan, Scotland, site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell-culture media, according to a Nov. 5, 2019 company press release.
"More and more customers are outsourcing their liquid manufacturing to ensure the highest quality while delivering efficiency," said Cory Stevenson, president of Thermo Fisher's bioproduction business, in the press release. "This investment will expand capabilities and expertise at our existing cell-culture manufacturing center of excellence in the UK to meet growing customer demand for our industry-leading bioproduction products."
The expansion is set to be complete by June 2021.
Source: Thermo Fisher Scientific
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
